Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …

The emergence of the monkeypox outbreak in early 2022 has posed a new global health
threat. As of July 8, 2022, 9069 laboratory-confirmed cases have been reported, and most of …

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
rapidly resulted in a global pandemic with approximately 4 million deaths. Effective oral …

The precocity and efficacy of the vaccines developed so far against COVID-19 has been the
most significant and saving advance against the pandemic. The development of vaccines …

Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-
hospital all-cause mortality in a lar Page 1 © The Author(s) 2021. Published by Oxford University …

Until now, no specific and effective treatment exists for coronavirus disease 2019 (COVID‐
19). Since honey and Nigella sativa (HNS) have established antiviral, antibacterial …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …

Background Remdesivir (RDV) improved clinical outcomes among hospitalized patients with
coronavirus disease 2019 (COVID-19) in randomized trials, but data from clinical practice …

This study investigated the effect of melatonin on clinical outcomes in patients with
coronavirus disease 2019 (COVID‐19). We searched PubMed, the Web of Science, the …

Recently, a novel coronavirus, known as severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has raised global concerns, being the etiological agent of the current …